Actinium Pharmaceuticals (ATNM) Q4 2024 Earnings

Nov 14Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.51
-0.44
-0.38
-0.31

Details

Expected EPS
-0.385
Actual EPS
-0.37
Surprise EPS
0.02
Surprise Percent
+3.9%

Description

⁨Actinium Pharmaceuticals⁩ (⁦ATNM⁩) has reported earnings of ⁦-0.37⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts